Epilog Partners is a private equity platform built by investors, operators, and innovators for healthcare's complexity.
The firm invests in tech-enabled payer and provider services and software and tech-enabled pharma services companies that are improving clinical, financial, and experiential outcomes.
Epilog targets equity investments of $50 to $200 million in leveraged buyouts of profitable, high-growth companies. Its efforts are guided by a research-centric, thesis-driven approach that informs where to invest and how to maximize value. This approach has resulted in completed platform investments, add-on acquisitions, recapitalization, and liquidity events with an aggregate transaction value of over $6 billion.
Portfolio Companies: Care Connectors, CareMetx, and ReceptRx (exited).
People
You last contacted this investor on .